CJC-1295 Dosage Chart & Schedule
A synthetic GHRH analog studied for stimulating growth-hormone release. Exists in a short-acting 'no-DAC' form (modified GRF 1-29) and a long-acting 'DAC' form.
Two forms differ sharply. The short-acting no-DAC (modified GRF 1-29) is commonly referenced at ~100 mcg per dose 1-2x daily, usually paired with a GHRP; the long-acting DAC form at ~1-2 mg once weekly. Not established in humans.
Figures describe how CJC-1295 is reported in the research literature and research-community references — not a recommendation for human use. For laboratory research only.
Dosage protocols
Commonly referenced research tiers. Start conservative; every compound and study context differs.
- Frequency
- 1-2x daily
- Weekly total
- 0.7-1.4 mg
- Cycle
- 8-12 weeks, then reassess
Modified GRF (1-29): short-acting (~30 min), timed to GH pulses and usually paired with a ghrelin-receptor agonist.
- Frequency
- Once weekly
- Weekly total
- 1-2 mg
- Cycle
- 8-12 weeks, then reassess
The albumin-binding Drug Affinity Complex extends half-life to days, allowing once-weekly dosing.
Two different molecules
- CJC-1295 no-DAC is modified GRF (1-29), short-acting (~30 min) and dosed daily like sermorelin.
- CJC-1295 DAC adds an albumin-binding complex that extends half-life to several days, so weekly milligram doses replace daily microgram doses.
Usually paired with a GHRP
- The no-DAC form is commonly referenced alongside a ghrelin-receptor agonist such as ipamorelin for a synergistic GH pulse.
- This pairing is a research convention and is not established in humans.
Ready to run this protocol?
Dosing is only as good as the vial. CJC-1295 is third-party tested with published COAs from our top-rated source — reconstitute with confidence and skip the guesswork on identity and purity.
Weekly schedule
A typical week on the no-dac protocol (1-2x daily).
Dosing day Off
CJC-1295 reconstitution
Based on a standard 5 mg vial: with 2 mL bacteriostatic water = 2,500 mcg/mL (2.5 mg/mL); 1 unit ≈ 25 mcg.
From vial to injection in 6 steps
Wipe both vial tops
Swab the peptide vial and the bacteriostatic-water vial with fresh alcohol and let them dry.
Draw the water
Pull the planned amount of bacteriostatic water (2 mL) into the syringe.
Add it slowly
Run the water down the inside wall of the vial — don't blast the powder. Swirl gently; never shake.
Let it dissolve
Wait until the solution is fully clear, then refrigerate the vial.
Draw your dose
Pull the calculated units on a U-100 insulin syringe (~4 units for 100 mcg).
Store between uses
Keep the reconstituted vial refrigerated and use within its stable window.
Handling & storage
- Reconstitute with bacteriostatic water (2 mL into a 5 mg vial = 2500 mcg/mL)
- Refrigerate reconstituted; keep the lyophilized powder cool and dark
- A 100 mcg dose draws to ~4 units on a U-100 insulin syringe
CJC-1295 dosing FAQ
How much CJC-1295 per dose?
For the no-DAC form, research references commonly cite ~100 mcg per injection, often 1-2x daily; the DAC form is referenced at ~1-2 mg once weekly. Not established in humans.
What is the difference between CJC-1295 DAC and no-DAC?
No-DAC (modified GRF 1-29) is short-acting and dosed daily; DAC binds albumin to extend its half-life to days, allowing once-weekly dosing.
How is CJC-1295 reconstituted?
With bacteriostatic water. For example, 2 mL into a 5 mg vial = 2500 mcg/mL, so a 100 mcg dose is about 4 units on a U-100 syringe.
Why is CJC-1295 stacked with ipamorelin?
A GHRH analog (CJC-1295) and a GHRP (ipamorelin) act on different receptors and are referenced together for a larger combined GH pulse. This is a research convention.
Sources
Categories: Growth Hormone Secretagogues · Status: Research use only. This page is educational and for laboratory research use only; it is not medical advice.